Physician profile
Thomas H Pae
NPI 1275635120
$4,359.40
in general payments reported to CMS, 2019-2025
30 companies · $960 in 2025
The $960 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,190 · 2020: $99.94 · 2021: $155 · 2022: $218 · 2023: $311 · 2024: $427 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,347 · Travel and Lodging: $330 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,347.24 |
| Travel and Lodging | $330.02 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,755.70 | 2019-2025 | |
| Davol INC. | $508.04 | 2019-2023 | Phasix Mesh |
| Csl Behring | $135.77 | 2020-2024 | Kcentra |
| Boston Scientific Corporation | $113.44 | 2019-2024 | Rezum Generator |
| Lemaitre Vascular, INC. | $96.68 | 2023-2025 | Artegraft Vascular Graft, Restoreflow |
| Kerecis Limited | $95.61 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Olympus America INC. | $57.02 | 2019-2023 | Itind System, Soltive |
| 180 Medical, INC. | $54.64 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.49 | 2023-2024 | Gattex |
| Merck Sharp & Dohme LLC | $43.21 | 2019-2024 | Lynparza, Keytruda |
| Tolmar Pharmaceuticals, INC. | $42.95 | 2019 | |
| Becton, Dickinson and Company | $38.94 | 2025 | Bard Urinary Drainage Bag, Magic3 Intermittent Catheter |
| Vertex Pharmaceuticals Incorporated | $37.44 | 2025 | |
| Myriad Genetic Laboratories, INC. | $35.57 | 2024 | Prolaris |
| Antares Pharma, INC. | $30.46 | 2025 | Xyosted |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Biosciences INC | $27.52 | 2019 | |
| Sumitomo Pharma America, INC. | $26.69 | 2025 | Gemtesa |
| Travere Therapeutics, INC. | $20.97 | 2020 | |
| Dendreon Pharmaceuticals LLC | $20.42 | 2019 | |
| Leica Microsystems INC. | $19.66 | 2019 | |
| Blue Earth Diagnostics | $18.58 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.13 | 2020 | |
| Clarus Therapeutics INC. | $17.82 | 2021 | |
| Monaghan Medical Corporation | $17.06 | 2023 | Aeroeclipse |
| Conmed Corporation | $15.86 | 2024 | Airseal |
| Procept Biorobotics Corporation | $14.14 | 2021 | |
| Teleflex LLC | $13.61 | 2021 | |
| Abbott Laboratories | $12.42 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.29 | 2019 | |
| Neotract INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Pae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.